Dataset Information


Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.

ABSTRACT: Fibroblast growth factor receptor 4 (FGFR4) is a transmembrane receptor with ligand-induced tyrosine kinase activity and is involved in various biological and pathological processes. Several polymorphisms of FGFR4 are associated with the incidence and mortality of numerous cancers, including prostate cancer. In this study, we investigated whether the polymorphisms of FGFR4 influence the biochemical recurrence of prostate cancer in Chinese men after radical prostatectomy. Three common polymorphisms (rs1966265, rs2011077, and rs351855) of FGFR4 were genotyped from 346 patients with prostate cancer by using the Sequenom MassARRAY system. Kaplan-Meier curves and Cox proportional hazard models were used for survival analysis. Results showed biochemical recurrence (BCR) free survival was significantly affected by the genotypes of rs351855 but not influenced by rs1966265 and rs2011077. After adjusting for other variables in multivariable analysis, patients with rs351855 AA/AG genotypes showed significantly worse BCR-free survival than those with the GG genotype (HR?=?1.873; 95% CI, 1.209-2.901; P?=?0.005). Hence, FGFR4 rs351855 could be a novel independent prognostic factor of BCR after radical prostatectomy in the Chinese population. This functional polymorphism may also provide a basis for surveillance programs. Additional large-scale studies must be performed to validate the significance of this polymorphism in prostate cancer.

PROVIDER: S-EPMC5027536 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7584815 | BioStudies
| S-EPMC6982237 | BioStudies
| S-EPMC7460457 | BioStudies
| S-EPMC5707095 | BioStudies
| S-EPMC4393280 | BioStudies
| S-EPMC2790323 | BioStudies
| S-EPMC8227855 | BioStudies
| S-EPMC4741823 | BioStudies
| S-EPMC5421931 | BioStudies
| S-EPMC3920085 | BioStudies